Acute iron intoxication: The efficacy of deferiprone and sodium biocarbonate in the prevention of iron absorption from the digestive tract

Veterinary and Human Toxicology

Volumn 41, Issue 5, 1999, Pages 308-311

  Barr, Joseph ^a   Berkovitch, Matitiahu ^a   Tavori, Irit ^a   Kariv, Noam ^b   Schejter, Abel ^b   Eshel, Gideon ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; DEFERIPRONE; FERROUS SULFATE; IRON;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GASTROINTESTINAL ABSORPTION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON CHELATION; IRON OVERLOAD; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STOMACH PH;

ANIMALS; DRUG INTERACTIONS; FECES; FEMALE; FERROUS COMPOUNDS; INTESTINAL ABSORPTION; IRON; IRON CHELATING AGENTS; PYRIDONES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 0032880793     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Litovitz T, Manoguerra A: Comparison of pediatric poisoning hazards: An analysis of 3.8 million exposure incidents. Pediatrics 89: 999-1006, 1992.
2. Litovitz TL, Selkstein M, Felberg L: 1996 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 15: 447-500, 1997.
3. Litovitz TL, Holm KL, Clancy C et al: 1992 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 11: 494-523, 1993.
4. Berkovitch M, Matsui D, Lamm SH et al: Recent increases in numbers and risk of fatalities in young children ingesting iron preparations. Vet Hum Toxicol 36: 53-55, 1994.
5. Bentur Y, McGuigan M, Koren G: Deferoxamine (desferrioxamine) new toxicities for an old drug. Drug-Saf 6: 37-46, 1991.
6. Whitten CF, Gileson GW, Good MH: Studies in acute iron poisoning. I: Deferoxamine in the treatment of acute poisoning: Clinical observations, experimental studies and theoretical considerations. Pediatrics 36: 322-335, 1965.
7. James JA: Acute iron poisoning assessment of severity and prognosis. J Pediatr 77: 117-119, 1970.
8. Fergusson PW, Stagy MP: Iron toxicity in the rats, an animal model for the undergraduate laboratory. Am J Pharm Education 41: 39-42, 1983.
9. Foman SJ: Bioavailability of supplemental iron in commercially prepared dry infant cereals. J Pediatr 110: 660-661, 1987.
10. Hallberg L, Brun GM: Low bioavalability of carbonil iron in man: Studies on iron portification of wheat flour. Am J Clin Nutr 43: 59-67, 1986.
11. Tenenbein M: Whole bowel irrigation in iron poisoning. J Pediatr 111: 142-145, 1987.
12. Tenenbein M, Weissman N, Yatscoff RW: Gastrostomy and whole bowel irrigation in iron poisoning. Pediatr Emerg Care 7: 286-288, 1991.
13. Geffner ME, Opas LM: Phosphate poisoning complicating treatment for iron ingestion. Am J Dis Child 134: 509-510, 1980.
14. Decker WJ, Combs HF, Cosby DG: Absorption of drugs and poisoning by activated charcoal. Toxicol Appl Pharmacol 13: 454-460, 1968.
15. Dean BS, Krenzelok EO: In vitro effectiveness oral complexation agents in the management of iron poisoning. Clin Toxicol 25: 221-230, 1987.
16. Bartlett AN, Hoffbrand AV, Kontoghiorghes GJ: Long term trial with the oral iron chelator 1.2 dimethyl 3-hydroxypyrid 4-one (L1) II. Clin Obs 76: 301-304, 1990.
17. Kontoghiorghes GJ, Bartlett AN, Hoffbrand AV et al: Long term trial with the oral iron chelator 1.2 dimethyl 3-hydroxypyrid 4-one (L1) I. Iron chelation and metabolic studies. Br J Haemotol 76: 295-300, 1990.
18. Olivieri NF, Koren G, Hermann C et al : Comparison of oral iron chelator L1 and desferioxamine in iron-loaded patients. Lancet 336: 1275-1279, 1990.
19. Berkovitch M, Laxer RM, Inman R et al : Arthropathy in thalassaemia patients receiving deferiprone. Lancet 343: 1472, 1994.
20. Olivieri NF, Brittenham JM, Matsui D et al: Iron chelation therapy with oral deferiprone in patients with thalassaemia major. N Eng J Med 332: 918-922, 1995.
21. Kont ghiorghes GJ: Orally active alpha1 ketohydroxy pyridine iron chelators studies in mice. Molecular Pharmacol 30: 670-673, 1986.
22. Kontoghiorghes GJ, Sheppard L, Hoffbrand AV et al: Iron chelation studies using desferrioxamine and the potent oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron overloaded rats. J Clin Pathol 40: 404-408, 1987.
23. Al Rafaie FM, Wonke B, Wolfbarons AV et al: Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood 3: 592-599, 1992.
24. Al Refaie FN, Sheppard LN, Nortey P et al : Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload. Br J Haematol 89: 403-408, 1995.
25. Berdoukas VA, Bentley P, Frost H et al : Toxicity of oral L1 (letter). Lancet 341: 1088, 1995.
26. Bergeron RJ, Streiff RR, Wiegand J et al : A comparison of the iron clearing properties of 1 ,2,-dimethyl-3-hydroxypyrid-4-one, 1,2,-diethyl-3-hydroxypyrid-4-one, and degeroxamine. Blood 79: 1882-1890, 1992.
27. Hershko C, Weatherall DJ: Iron chelating therapy. CRC Crit Rev Clin Lab Sci 26:" 303-344, 1988.
28. Bentur Y, Klein J, Levy M et al: Methodological issues in studying the effect of the new oral chelator 1 ,2,-dimethyl-3-hydroxypyrid-4-one (L1) on absorption of iron. Vet Hum Toxicol 32: 159-161, 1990.
29. Cameron BF: Determination of iron in heme compounds II: Hemoglobin and myoglobin. Analytical Biochem 11: 164-169, 1965.
30. Hiliard EP, Smith JD: Minimum sample preparation for the determination of ten elements in pig feces and geeds by atomic absorption spectrophotometry and a spectrophotometric procedure total phosphorus. Analyst 104: 313-322, 1979.
31. Charles River Laboratories: Baseline hematology and clinical chemistry values for rats as a function of sex and age. Charles River Technical Bulletin 3, (2), 1984.
32. Jacobs P, Wormald LA, Gregory MC: Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study. S Afr Med J 55: 1065-1072, 1979.
33. Nayfield SG, Kent TH, Rodman NF: Gastrointestinal effects of acute ferrous sulfate poisoning in rats. Arch Pathol Lab Med 100: 325-328, 1976.
34. Schwartz WK, Oderda GM, Gorman RL et al: Assessment of managements guidelines-Acute iron ingestion. Clin Pediatr 29: 316-321, 1990.
35. Schafer S, Forth W: On the absorption of divalent and trivalent iron in living rats. Arzneim-Forsch/Drug Res 34: 1570-1574, 1984.
36. Kontoghiorghes GJ, Aldouri MA, Sheppard L: 1,2 Dimethyl-3-hydroxypyrid 4-one an orally active chelator for treatment of iron overloads. Lancet I: 1294-1295, 1987.
37. Kontoghiorghes GJ, Goddard JG, Bartlett AM et al: Pharmacokinetic studies in humans with the oral iron chelator 1,2,-dimethyl-3-hydroxypyrid-4-one. Clin Pharmacol 48: 255-261, 1990.
38. Fassos FF, Klein J, Fernandes D et al: The pharmacokinetics and pharmacokynamics of oral iron chelator deferipron (L1) in relation to hemoglobin levels. Int J Clin Pharmacol Ther 34: 288-292, 1996.